Literature DB >> 21270288

Re-evaluation of the genome sequence of guinea pig cytomegalovirus.

Kyosuke Kanai1, Souichi Yamada1, Yumiko Yamamoto1, Yoshiko Fukui1, Ichiro Kurane1, Naoki Inoue1.   

Abstract

Congenital infection by human cytomegalovirus (HCMV) is a major cause of birth defects and developmental abnormalities. Since guinea pig cytomegalovirus (GPCMV) crosses the placenta and causes infection in utero, GPCMV models are useful for studies of the mechanisms of transplacental transmission. During our characterization of a genomic locus required for GPCMV dissemination in animals, we found that the nucleotide sequence in and around the nearby immediate-early genes in our lineage of GPCMV strain 22122 [designated GPCMV (ATCC-P5)] showed clear differences from that reported previously for the same strain [designated GPCMV (UMN)] passaged extensively in vitro. Since in vitro passaging of HCMV is known to result in genetic alterations, especially in the UL128-UL131A locus, and loss of growth ability in particular cell types, in this study we determined the complete genome sequence of GPCMV (ATCC-P5), which grows efficiently in animals. A total of 359 differences were identified between the genome sequences of GPCMV (UMN) and GPCMV (ATCC-P5), and these resulted in structural differences in 29 protein-encoding regions. In addition, some genes predicted from our analysis but not from GPCMV (UMN) are well conserved among cytomegaloviruses. An additional 18 passages of GPCMV (ATCC-P5) in vitro generated no further marked alterations in these genes or in the locus corresponding to the HCMV UL128-UL131A. Our analyses indicate that the published sequence of GPCMV (UMN) contains a substantial number of sequencing errors and, possibly, some mutations resulting from a long history of passaging in vitro. Our re-evaluation of the genetic content of GPCMV will provide a solid foundation for future studies.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21270288     DOI: 10.1099/vir.0.027789-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  19 in total

1.  Maternal CD4+ T cells protect against severe congenital cytomegalovirus disease in a novel nonhuman primate model of placental cytomegalovirus transmission.

Authors:  Kristy M Bialas; Takayuki Tanaka; Dollnovan Tran; Valerie Varner; Eduardo Cisneros De La Rosa; Flavia Chiuppesi; Felix Wussow; Lisa Kattenhorn; Sheila Macri; Erika L Kunz; Judy A Estroff; Jennifer Kirchherr; Yujuan Yue; Qihua Fan; Michael Lauck; David H O'Connor; Allison H S Hall; Alvarez Xavier; Don J Diamond; Peter A Barry; Amitinder Kaur; Sallie R Permar
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-19       Impact factor: 11.205

2.  A novel bat herpesvirus encodes homologues of major histocompatibility complex classes I and II, C-type lectin, and a unique family of immune-related genes.

Authors:  Huajun Zhang; Shawn Todd; Mary Tachedjian; Jennifer A Barr; Minhua Luo; Meng Yu; Glenn A Marsh; Gary Crameri; Lin-Fa Wang
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

3.  Neutralizing antibodies to gB based CMV vaccine requires full length antigen but reduced virus neutralization on non-fibroblast cells limits vaccine efficacy in the guinea pig model.

Authors:  K Yeon Choi; Nadia S El-Hamdi; Alistair McGregor
Journal:  Vaccine       Date:  2020-01-31       Impact factor: 3.641

4.  Cytomegalovirus UL128 homolog mutants that form a pentameric complex produce virus with impaired epithelial and trophoblast cell tropism and altered pathogenicity in the guinea pig.

Authors:  Stewart Coleman; K Yeon Choi; Alistair McGregor
Journal:  Virology       Date:  2017-06-23       Impact factor: 3.616

5.  Reevaluation of the coding potential and proteomic analysis of the BAC-derived rhesus cytomegalovirus strain 68-1.

Authors:  Daniel Malouli; Ernesto S Nakayasu; Kasinath Viswanathan; David G Camp; W L William Chang; Peter A Barry; Richard D Smith; Klaus Früh
Journal:  J Virol       Date:  2012-06-20       Impact factor: 5.103

6.  Genomic sequencing and characterization of cynomolgus macaque cytomegalovirus.

Authors:  Angie K Marsh; David O Willer; Aruna P N Ambagala; Misko Dzamba; Jacqueline K Chan; Richard Pilon; Jocelyn Fournier; Paul Sandstrom; Michael Brudno; Kelly S MacDonald
Journal:  J Virol       Date:  2011-10-12       Impact factor: 5.103

Review 7.  Maternal immune correlates of protection against placental transmission of cytomegalovirus.

Authors:  Hannah L Itell; Cody S Nelson; David R Martinez; Sallie R Permar
Journal:  Placenta       Date:  2017-04-20       Impact factor: 3.481

8.  The Human Cytomegalovirus UL116 Gene Encodes an Envelope Glycoprotein Forming a Complex with gH Independently from gL.

Authors:  Stefano Caló; Mirko Cortese; Claudio Ciferri; Luca Bruno; Rachel Gerrein; Barbara Benucci; Giuseppina Monda; Michela Gentile; Tobias Kessler; Yasushi Uematsu; Domenico Maione; Anders E Lilja; Andrea Carfí; Marcello Merola
Journal:  J Virol       Date:  2016-04-29       Impact factor: 5.103

9.  A Novel Non-Replication-Competent Cytomegalovirus Capsid Mutant Vaccine Strategy Is Effective in Reducing Congenital Infection.

Authors:  K Yeon Choi; Matthew Root; Alistair McGregor
Journal:  J Virol       Date:  2016-08-12       Impact factor: 5.103

10.  Targeted Mutagenesis of Guinea Pig Cytomegalovirus Using CRISPR/Cas9-Mediated Gene Editing.

Authors:  Craig J Bierle; Kaitlyn M Anderholm; Jian Ben Wang; Michael A McVoy; Mark R Schleiss
Journal:  J Virol       Date:  2016-07-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.